Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLS-002 in PTSD
NCT06816433Phase 2Suspended
- Sponsor
- Global Coalition for Adaptive Research
- Start
- May 2028
- Primary completion
- May 2029
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SLS-002 in post-traumatic stress disorder (PTSD), sponsored by Global Coalition for Adaptive Research. Planned start May 2028; status: suspended.
02
Drugs
SLS-002
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06816433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06816433.